Background
Adenotonsillectomy is associated with significant post-operative pain especially in children, and its management remains a dilemma for the anaesthetist [1]. Failure of achieving good analgesia in children who undergo tonsillectomy and/or adenoidectomy will cause poor oral intake, which leads to oropharyngeal oedema due to non-mobility of the soft palate lassitude, delayed recovery of strength and well-being and occasionally requires overnight hospitalization in day-case surgical practice [2]. Thus, different methods have been studied and used to reduce pain, including improved intraoperative anaesthetic pain regimens, use of corticosteroids, adjustment of surgical technique and intraoperative local anaesthetic injection [3]. Tonsillectomy produces large areas of exposed muscle in the oropharynx, resulting in considerable pain from muscle spasm, irritation of nerve endings, and excessive dissection, and the use of cautery for haemostasis may produce even greater amount of inflammation and post-operative pain [4]. Many considerations are involved in the choice of analgesic for the management of pain in paediatric patients undergoing these procedures. Essential requirements include good analgesia, reduction in opioid-related respiratory depression, low risk of inducing nausea and vomiting precluding early alimentation and more importantly no risk of bleeding. Good quality, effective management of pain following adenotonsillectomy in children is therefore an essential component of paediatric ENT anaesthesia.
Various strategies have been proposed for the management of post-tonsillectomy pain like infiltration of the tonsillar fossae with local anaesthetic agents [5, 6], non-steroidal anti-inflammatory drugs (NSAID) [7], narcotic analgesics and oral analgesics [7]. The use of parenterally administered analgesics in the immediate post-operative period is the common practice in our hospital, which is usually associated with laryngeal spasm especially if the patient does not receive adequate analgesia, or patient is not fully awake and in a light plane of anaesthesia.
A potentially beneficial principle to adhere to for acute post-operative pain management is that local anaesthetics should be part of the initial pain management plan. Application of local anaesthetics to the surgical site either before or after the procedure by infiltration or topical administration has been used by many researchers for post-adenotonsillectomy pain management, with great discrepancy [8, 9]. Indeed, life-threatening upper airway obstruction after bupivacaine infiltration has been reported in children [10]. On the other hand, topical administration of bupivacaine hydrochloride has been found to provide an efficient pain control following tonsillectomy without any drug-related complication [4]. In order to avoid potential side effects of the infiltration technique, this study is set to investigate the effectiveness of topical plain bupivacaine for post-adenotonsillectomy pain in our institution.
Methods
Following ethical approval, the patients recruited for this study were consented patients scheduled for adenotonsillectomy.
Sample determination
This was calculated using the formula for sample size determination when comparing two means:n = minimum sample size for each group.
σ1, σ0 = Standard deviations.
µ1—µ0 = Difference between the means.
u = One-sided percentage point of the normal distribution corresponding to 100% — the power. Power is set at 80%; therefore, u = 0.84.
v = Percentage point of the normal distribution corresponding to the (two-sided) significance level set at 5% therefore v = 1.96.
A similar study found 5-h post surgery pain scores of 0.51 ± 0.12 and 0.42 ± 0.22 in subjects who received topical bupivacaine and lidocaine/adrenaline, respectively 4.
A total of 120 patients were studied.
Study design
This was a prospective study in which 120 children, aged 2–15 years and ASA I or II of consenting parents undergoing adenoidectomy and/or tonsillectomy during the study period were enrolled into the study. All patients for the procedures were admitted a day prior to the surgery after showing normal results for routine investigations. The patients were divided into 2 study groups by randomly picking of group from an envelope. The first group (A) patients received 5 ml of 0.125% bupivacaine-soaked swab applied directly on the tonsillar fossae and/or nasopharynx after haemostasis was secured for 5 min before discontinuation of anaesthesia.
The second group (B) patients received gauze soaked in an equal volume of lidocaine/adrenaline mixture (1 in 4 dilutions of 2% lidocaine plus 1:200,000 adrenaline).
Inclusion criteria
All children scheduled for adenoidectomy and/ or tonsillectomy within the age range 2–15 years.
Exclusion criteria
Underlying chronic diseases like, but not limited to sickle cell disease (SCD).
Synchronous surgical procedure in addition to adenotonsillectomy, e.g. myringotomy.
Patients on regular/routine analgesic medications.
Failure of parents to give consent.
Patients with history of allergy to study drugs.
Anaesthesia management
Standard general anaesthesia (GA) with endotracheal intubation and relaxant technique with intermittent positive pressure ventilation (IPPV) was administered, and intravenous paracetamol 10–15 mg/kg and intravenous fentanyl 2 µg/kg for intraoperative analgesia were given just before the commencement of surgery in the two groups.
The study drugs were applied by the Otorhinolaryngologist after ensuring adequate haemostasis by soaking appropriate size gauze packs with 5 ml of the study drugs adequate enough to fill each of the fossae of the adenoid and tonsillar beds for 5 min.
Adenoidectomy was carried out by curettage and tonsillectomy using the cold steel dissection method. Haemostasis was secured by swab packing for 5 min. The surgeries were performed by a Consultant Otorhinolaryngologist or Otorhinolaryngology resident who has had a similar level of experience under supervision.
All patients were extubated awake in the operating room after the removal of the pharyngeal pack and transferred to the recovery room.
In the recovery room, vital signs were monitored, and during this interval, any instance of crying, vomiting or agitation was recorded. The recovery room nurses and pain score observers were blinded to the identity of the study drugs. The time to eye opening to command (from the time of discontinuation of anaesthetic to opening of the eye) was noted while the pain scores were assessed using the modified Children’s Hospital of Eastern Ontario Pain Scale (mCHEOPS) [11] (Appendix 1) for children less than 4 years and a verbal Rating Scale [12] for children above 4 years (Appendix 2).
The scoring was done at fixed intervals after the procedure every 15 min in the recovery room for the first 1 h, then every 30 min for the next 3 h, and in the ward every 2 h for the next 20 h, i.e. 0, 15, 30, 45 and 60 min and 0, 30, 60, 90, 120, 150 and 180 min then 0, 2, 4, 6 h, etc. respectively post-operatively for each patient. All scoring was done by an attending resident blinded to the study groups. A pain score of 4 and above was assumed to be an indication for the administration of analgesics and the time was taken as time to first analgesic request.
The level of satisfaction of pain control was assessed for each patients’ group using a 5-point Likert scale [13] (Appendix 3) response of patients or parents/guardians to the statement.
Post-operative complications like laryngeal spasm, nausea, vomiting and dysphagia to solid or liquid diets were observed and recorded.
Primary outcome measures.
Post-operative pain scores in both groups
Immediate airway complications following extubation in the groups
Secondary outcome measures.
Side effects of bupivacaine
Side effect of lidocaine/adrenaline mixture
Haemodynamic changes (heart rate, systolic blood pressure, diastolic blood pressure, mean arterial blood pressure, peripheral arterial oxygen saturation and rate pressure product) in the immediate post-operative period in the groups
Patients’ level of satisfaction in the study groups
Data analysis
Data obtained was analyzed using Statistical Package for Social Science (SPSS) version 22 applying univariate, bivariate and multivariate analysis. Nominal data were presented as percentages and analyzed using the chi-square test, while ordinal variables were presented in median and range and analyzed using the Mann–Whitney U test. Continuous variables were presented in means and standard deviation and analyzed using the paired Student’s T-test. A p-value of < 0.05 was considered statistically significant.
Results
A total of 120 patients were recruited for the study comprising 56 patients in the bupivacaine group and 64 in the lidocaine group. All the patients were ASA 1. The male-to-female ratio of the bupivacaine vs lidocaine group was 34:22 versus 37:27, respectively (p-value 0.764) (Table 1). There was no difference in the two groups in the other demographic data as shown in Table 1. Eleven (9.2%) patients were operated for tonsillar enlargement alone comprising 5 patients in the lidocaine group (L) and 6 in the bupivacaine group (B) while 109 (90.8%) for adenotonsillar enlargement as shown in Table 1. All were elective surgeries.
Table 1. Demographic characteristics
Bupivacaine | Lidocaine | p-value | |
---|---|---|---|
Age (years) | Mean (SD) | Mean (SD) | |
Weight (Kg) | 5.1316 (3.164) | 5.875 (4.402) | 0.182 |
Height (m) | 19.5 (9.56) | 21.0156 (10.122) | 0.338 |
Indication | 1.0845 (0.10016) | 1.1046 (0.19896) | 0.311 |
Adenotonsillar enlargement* | 51(46.8%) | 5(45.5%) | 0.932 |
Tonsillar enlargement* | 58(53.2%) | 6(55.5%) | |
Gender | |||
Male* | 34 (60.7%) | 37 (57.8%) | 0.746 |
Female* | 22 (39.3%) | 27 (42.2%) |
*numbers (percentage)
p-value is level of significance
SD= Standard Deviation
The mean baseline pulse rate (bpm) in the bupivacaine group versus the lidocaine group was 106.18 (9.475) and 107.42 (8.017), respectively (p-value 0.241), while the mean baseline systolic blood pressure (mmHg) in groups B vs L was 90.92 (3.649) vs 92.13 (6.275), respectively (p-value 0.141). Also, the mean baseline diastolic blood pressure in groups B vs L was 70.18 (0.865) vs 70.16 (1.250) respectively (p-value 0.451). Similarly, there was no difference in the mean baseline peripheral oxygen saturation as shown in Table 2. A total of 46 patients (82.1%) of the group size were extubated calmly in group B as against 29 (45.3%) in the L group (p-value 0.0001). The details of the remaining extubating conditions are shown in Table 3. The result showed that 37 (66.1%) and 45 (70.3%) of the patients in groups B and L opened their eyes within 5 min of discontinuation of anaesthesia, respectively. Overall, there was no difference in the time from discontinuation of anaesthesia to eye opening in both groups (p-value 0.316), as shown in Table 4. All the patients in the lidocaine group had a time to first analgesic request between 1 and 6 h, whereas in the bupivacaine group, about 25 patients (44% of the group) had a time to first analgesic request that exceeded 6 h (6–10 h). Overall, there was no statistical difference in the time to the first analgesic requirement in both groups as shown in Table 5. The only complication recorded in both groups following oral feeds was vomiting. In the bupivacaine group, the number of patients who had no complications versus the lidocaine group was 50 (89.55%) versus 57 (89.1%), respectively, while 6 (10.5%) and 7(10.9%) patients vomited in the bupivacaine and lidocaine groups following oral feeds respectively (p-value 0.968), as shown in Table 6. Thirty-four parents (60.7%) in the bupivacaine group and nine (14.0%) in the lidocaine group were very satisfied, respectively (p-value 0.00001). The details of the parental satisfaction scores are in Table 7.
Table 2. Showing Mean Baseline Haemodynamic variables
Bupivacaine | Lid+ Adrenaline | p-Value | |
---|---|---|---|
Pulse rate | 106.18(9.475) | 107.42 (8.017) | 0.241 |
Systolic blood pressure | 107.42 (8.017) | 107.42 (8.017) | 0.141 |
Diastolic blood pressure | 70.18 (0.865) | 70.16 (1.250) | 0.451 |
Peripheral oxygen saturation. | 98.08 (0.359) | 98.03 (0.435) | 0.978 |
Mean (SD)
Table 3. Showing extubating conditions of the patients
Extubating conditions | Total | |||
---|---|---|---|---|
Calm | Crying | Restless | ||
Bupivacaine | 46 (82.1%) | 7 (12.5%) | 3 (5.4%) | 56 |
Lid+ Adrenaline | 29(45.3%) | 20(31.3%) | 15(23.4%) | 64 |
Total | 75 | 27 | 18 | 120 |
P value =0.0001
Table 4. showing time(mins) from end of anaesthesia to eye opening
Time from end of anesthesia to eye opening | Total | |||||
---|---|---|---|---|---|---|
</=3mins | 4mins | 5mins | 6mins | >/=7mins | ||
Bupivacaine | 7(12.5%) | 13(23.2%) | 17(30.4%) | 6(10.7%) | 13(23.2%) | 56 |
Lid+ Adrenaline | 12(18.8%) | 11(17.2%) | 22(34.4%) | 7(10.9%) | 12(18.8%) | 64 |
Total | 19 | 24 | 39 | 13 | 25 | 120 |
P value 0.316
Table 5. showing time(hours) to first analgesic requirement
Time (hours) | Bupivacaine | Lidoacaine+ Adr | Total |
---|---|---|---|
1 | 2 | 5 | 7 |
2 | 0 | 12 | 12 |
3 | 0 | 10 | 10 |
4 | 9 | 27 | 36 |
5 | 10 | 5 | 15 |
6 | 10 | 5 | 15 |
7 | 6 | 0 | 6 |
8 | 12 | 0 | 12 |
9 | 3 | 0 | 3 |
10 | 4 | 0 | 4 |
Total | 56(46.7%) | 64(53.3%) | 120 |
Numbers, p value = 0.413
Table 6. showing the incidence of complication with oral feed in both groups
Presence of complication | Total | ||
---|---|---|---|
Yes (vomiting) | No | ||
Bupivacaine | 6 (10.5%) | 50 (89.55%) | 56 (46.7%) |
Lidocaine+Adr | 7(10.9%) | 57 (89.1%) | 64 (53.3%) |
Total | 13(10.8%) | 107 (89.2%) | 120 |
p-value 0.968
Table 7. shows Parental Satisfaction
Parental Satisfaction | Total | |||
---|---|---|---|---|
Unsure | Satisfied | Very satisfied | ||
Bupivacaine | 3(5.4%) | 19(33.9%) | 34(60.7%) | 56 (46.7%) |
Lidocaine+Adr | 3(4.7%) | 52(81.3%) | 9(14.0%) | 64 (53.3%) |
Total | 6 (0.05%) | 71(59.2%) | 43(35.8%) | 120 |
p-value= 0.00001
Discussion
Overall, the study demonstrated similar time to eye opening, analgesic request, haemodynamic parameters and incidence of complications, whereas patients in the bupivacaine group had better extubation conditions and consequently better parental satisfaction.
Tonsillectomy is one of the commonest ENT surgeries performed in the paediatric age grade. It can also lead to significant post-operative pain. Post-tonsillectomy pain is common and under reported and may result in poor oral intake, dehydration, sleep disturbances, behavioural changes and emesis and late haemorrhage [4]; thus, post-operative pain control is an essential part of routine oral surgical procedures as it also encourages movement of the soft palate with a reduction in oedema and aspiration from lazy palatal movement. The institution of a multimodal analgesic regimen before the child awakes from GA will have a preemptive analgesic effect and ensure a smooth transition. Different methods have been used to reduce pain, including improved intraoperative anaesthetic pain regimens, intraoperative local anaesthesia infiltration or topical application in the peritonsillar space [14]. The intensity of post-tonsillectomy pain has been known to be reduced by local administration of lidocaine with adrenaline [15] although ENT surgeons tend to prefer the use of bupivacaine with or without adrenaline [4, 14, 16]. Both are amide local anaesthetic agents and very potent, and although bupivacaine is longer acting, the addition of adrenaline to lidocaine increases its duration of action and in some cases has been comparable to bupivacaine in terms of analgesic duration [17]. Although more patients in the bupivacaine group have longer time to first analgesic request, the overall pain control was similar in both groups. This agrees with the findings of Ozmen et al. [4] but not with that of Ozkris et al. [14]. Ozkris et al. [14] found that the difference between the mean pain score of the bupivacaine versus lidocaine groups was statistically significant (p < 0.001). This could be because they employed bupivacaine with adrenaline in their study unlike plain bupivacaine that was used in this study. Adrenaline has been known to improve the duration of local anaesthetic by decreasing systemic absorption through local vasoconstriction. Although meta-analysis showed that the effect of adrenaline on prolonging the duration of bupivacaine could not be conclusively proven, some studies did report otherwise [18]. In our study, lidocaine with adrenaline did not confer analgesic properties beyond 6 h post-operatively. However, in the bupivacaine group, the time to first analgesic requirement was prolonged beyond 6 h in about 44.6% of the subgroup. This suggests that though the time to first analgesic request in both groups was comparable especially in the immediate post-operative period, in the long term, bupivacaine may offer extended analgesia more than lidocaine. This finding may be because of the prolonged duration of action of bupivacaine which is about 4–8 h [19]. There is a paucity of studies comparing time to first analgesic request following tonsillectomy in paediatric patients. This could be because of study design challenges. The paediatric age group is heterogenous varying from those who cannot verbalize and rely on emotions to communicate (infants) to those who can verbalize to communicate effectively, and this could affect the ability to accurately know the exact time to first analgesic request. Assessment of post-operative pain in children can be challenging as the child may be unable to properly communicate and verbalize and may cry due to phobia of blood, fear of strangers, needle phobia, pain or a combination of these [20]. Thus, specific tools have been employed in pain assessment in children to adequately determine the time to first analgesic request. These include FLACC scale [21], Wong Baker’s scale [22], verbal rating scale [12] and the modified CHEOPS pain score which has shown good reliability, validity and good inter observer variability [4, 11, 20]. The method employed in this study to determine the time to first analgesic is a reliable and validated method for that purpose [12, 20–22]. Hung et al. [23] also found that compared to placebo, topical bupivacaine reduced post-operative pain scores and prolonged the time to first analgesic request in paediatric day-case tonsillectomy in the first 6 h. Similarly, Ozmen et al. [4] showed that topical bupivacaine improved post-operative pain compared to lidocaine and placebo after the fifth hour. This is comparable to our study because all the patients in the lidocaine group had a time to first analgesic request less than or equal to 6 h, whereas 44% in the bupivacaine group had extended time to first analgesic request beyond 6 h up to 10 h. This finding by Ozmen et al. [4] continued until the sixth day and in some literatures up to 10 days [24, 25].
The concentration of bupivacaine and lidocaine employed in this study has been proven to be safe by meta-analysis and Cochrane studies [15], and indeed, higher concentrations of bupivacaine have resulted in serious life-threatening complications [10], although a lot of studies had previously employed infiltration of local anaesthetic agents at the tonsillar pillars with variable results. For example, while some found that it provided sufficient pain control [26, 27], others found otherwise [28]. However, the choice of infiltration of the tonsillar pillar which is very vascular carries a worrisome risk of accidental intravascular injection and its attendant complications including arrhythmias, cardiac arrest, convulsion, airway obstruction, facial nerve paralysis, vocal cord paralysis and brainstem stroke [4, 10, 17, 18]. Hence the choice of topical application with swab in this study as was also employed by Ozmen et al. [4] whose findings also agreed with us that topical application with swabs provided adequate pain relief while avoiding complications. This study found that topical application of local anaesthetic was associated with lower incidences of complications associated with tonsillectomy, and this agrees with the findings of Haksever et al. [29]. Haksever and colleagues [29] noticed a significant decrease in immediate post-operative pain, significant reduction in the incidence of post-operative morbidities such as trismus, nausea, vomiting and otalgia, excessive crying and vomiting and all these equated to better patient recovery, improved service delivery and outcome and better parental satisfaction with the entire surgical and anaesthetic process. Likewise, Ozmen et al. [4] noted that topical application was associated with a decrease in the incidence of post-operative pyrexia, halitosis, nausea, vomiting and otalgia. In fact, meta-analyses of studies done using local application of local anaesthetic agents have demonstrated that the vasoconstrictive effects of these agents were associated with improved post-operative haematological parameters possibly through decreased blood loss, and all these will help to decrease the likelihood of post-tonsillectomy bleed and perioperative transfusions especially in the paediatric age group [25, 30].
Conclusion
Topical application of bupivacaine was associated with better extubation conditions and parental satisfaction when compared to topical lidocaine plus adrenaline while both demonstrated similar time to eye opening, analgesic request, haemodynamic parameters and incidence of complications.
Acknowledgements
Thanks to all the patients who consented and participated in this study.
Authors’ contributions
OO conceived the idea, designed and drafted the manuscript. OA analyzed the data and reviewed the manuscript. BO reviewed the manuscript. EI and A wrote the discussion and collected the data. SO, AO and AD performed the surgery and reviewed the manuscript. OO did the manuscript writing and final editing of this article. All the authors read and approved the final version of the manuscript.
Funding
The study was sponsored solely by the authors.
Availability of data and materials
The datasets used and/or analyzed during this study are available from the corresponding author on reasonable request.
Declarations
Ethics approval and consent to participate
Obtained from the institution Ethical Review Committee of the University of Ilorin Teaching Hospital and each patient's completed an informed consent form before taking part in the study.
Consent for publication
An informed written consent for publication had been obtained from the patient’s parent.
Competing interest
The authors declared that they have no competing interests.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
1. Wong, A; Bissonnette, B; Braude, B; Macdonald, R; St-Louis, E; Fear, D. Post- tonsillectomy infiltration with bupivacaine reduces immediate postoperative pain in children. Can J Anaesth; 1995; 42,
2. Ertugrul, F; Akbas, M; Karsli, B; Kayacan, N; Bulut, F; Trakya, A. Pain relief for children after adenoidectomy. J Int Med Res; 2006; 34, pp. 648-654.[COI: 1:CAS:528:DC%2BD2sXitV2itL8%3D] [DOI: https://dx.doi.org/10.1177/147323000603400610] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17294997]
3. Akoglu, E; Akkurt, C; Inanoglu, K; Okuyucu, S; Daglı, S. Ropivacaine compared to bupivacaine for post-tonsillectomy pain relief in children: a randomized controlled study. Int J Pediatr Otorhinolaryngol; 2006; 70, pp. 1169-1173. [DOI: https://dx.doi.org/10.1016/j.ijporl.2005.12.001] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16414124]
4. Ozmen, A; Ozmen, S. Topical bupivacaine compared to lidocaine with epinephrine for post-tonsillectomy pain relief in children: a randomized controlled study. Int J Pediatr Otorhinolaryngol; 2011; 75, pp. 77-80. [DOI: https://dx.doi.org/10.1016/j.ijporl.2010.10.013] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21067823]
5. Jebeles, J; Reilly, J; Gutierrez, I; Bradley, E, Jr; Kissin, I. The effect of preincisional infiltration of tonsils with bupivacaine on the pain following tonsillectomy under general anaesthesia. Pain; 1991; 47, pp. 305-308. [DOI: https://dx.doi.org/10.1016/0304-3959(91)90220-R] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1784501]
6. Stuart, J; MacGregor, F; Cairns, C; Chandrachud, H. Peritonsillar infiltration with bupivacaine for paediatric tonsillectomy. Anaes Intensive care; 1994; 22, pp. 679-682.[COI: 1:STN:280:DyaK2M3gtVSqsA%3D%3D] [DOI: https://dx.doi.org/10.1177/0310057X9402200606]
7. Watters, C; Patterson, C; Mathews, H; Campbell, W. Diclofenac sodium for post-tonsillectomy pain in children. Anaesthesia; 1988; 43, pp. 641-643.[COI: 1:STN:280:DyaL1czjvV2ntg%3D%3D] [DOI: https://dx.doi.org/10.1111/j.1365-2044.1988.tb04147.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3421455]
8. Costas-Gastiaburo, LA; Rajah, V; Rubin, J. Tonsillectomy and the value of peritonsillar infiltrations. S Afr J Surg; 1998; 36,
9. Nordahl, S; Albrektsen, G; Guttormsen, A; Pedersen, I; Breidablikk, H. Effect of bupivacaine on pain after tonsillectomy: a randomized clinical trial. Acta Otolaryngol; 1999; 119,
10. Bean-Lijewski, J. Glossopharyngeal nerve block for pain relief after paediatric tonsillectomy: retrospective analysis and two cases of life-threatening upper airway obstruction from an interrupted trial. Anesth Analg; 1997; 184, pp. 1232-1238. [DOI: https://dx.doi.org/10.1213/00000539-199706000-00011]
11. Splinter, M; Semelhago, L; Chou, S. The reliability and validity of a modified CHEOPS pain score. Anesth Analg; 1994; 78, pp. 413-415.
12. Soyannwo, O; Amanor-Boadu, S; Sanya, O; Gureje, O. Pain assessment in Nigerians- verbal rating scale and visual analogue scale compared. West Afr J Med; 2000; 19,
13. Page, D; Taylor, D. Vapocoolant spray vs subcutaneous lidocaine injection for reducing the pain of intravenous cannulation : a randomized, controlled, clinical trial. Br J Anaesth; 2010; 105, pp. 519-525.[COI: 1:CAS:528:DC%2BC3cXhtFylt7vM] [DOI: https://dx.doi.org/10.1093/bja/aeq198] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20682573]
14. Özkiriş, M; Kapusuz, Z; Saydam, L. Comparison of ropivacaine, bupivacaine and lidocaine in the management of post-tonsillectomy pain. Int J Pediatr Otorhinolaryngol; 2012; 76,
15. Su, N; Wang, H; Zhang, S; Liao, S; Yang, S; Huang, Y. Efficacy and safety of bupivacaine versus lidocaine in dental treatments: a meta-analysis of randomised controlled trials. Int Dent J; 2014; 64,
16. Melchor, MA; Villafruela, MA; Muñoz, B; Domingo, C; Ontañón, M; García, A et al. Postoperative pain in tonsillectomy in general anesthesia and local infiltration. Acta Otorrinolaringol Esp; 1994; 45,
17. Collins, JB; Song, J; Mahabir, RC. Onset and duration of intradermal mixtures of bupivacaine and lidocaine with epinephrine. Can J Plast Surg; 2013; 21,
18. Tschopp, C; Tramèr, MR; Schneider, A; Zaarour, M; Elia, N. Benefit and harm of adding epinephrine to a local anesthetic for neuraxial and locoregional anesthesia: a meta-analysis of randomized controlled trials with trial sequential analyses. Anesth Analg; 2018; 127,
19. Erin B. Bupivacaine versus lidocaine local anesthesia - full text view - ClinicalTrials.gov. ClinicalTrials.gov. 2015. p. 1–7. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT01751347. Cited 2023 Jul 10
20. Abadie A, Angrist J, Imbens G (1999) Childrens-Hospital-of-Eastern-Ontario-Pain-Scale-CHEOPS. University of Florida, p 1–3. Available from: https://pami.emergency.med.jax.ufl.edu/files/2015/02/Childrens-Hospital-of-Eastern-Ontario-Pain-Scale-CHEOPS.pdf.
21. Shamim, F; Ullah, H; Khan, FA. Postoperative pain assessment using four behavioral scales in Pakistani children undergoing elective surgery. Saudi J Anaesth; 2015; 9,
22. Walker BJ, Polaner DM, Berde CB (2019) Acute pain. In: A practice of anesthesia for infants and children. Elsevier, chapter 44 p 1023–1062.e15
23. Hung, T; Moore-Gillon, V; Hern, J; Hinton, A; Patel, N. Topical bupivacaine in paediatric day-case tonsillectomy: a prospective randomized controlled trial. J Laryngol Otol; 2002; 116, pp. 33-36.[COI: 1:STN:280:DC%2BD387isVehuw%3D%3D] [DOI: https://dx.doi.org/10.1258/0022215021910311] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11860649]
24. Jebeles, JA; Reilly, JS; Gutierrez, JF; Bradley, EL, Jr; Kissin, I. Tonsillectomy and adenoidectomy pain reduction by local bupivacaine infiltration in children. Int J Pediatr Otorhinolaryngol; 1993; 25,
25. Wang, J; Wang, N; Gong, F. Efficacy of bupivacaine infiltration for controlling post-tonsillectomy pain, duration of surgery and post-operative morbidities: a systematic review and meta-analysis. Exp Ther Med; 2021; 21,
26. Somdas, MA; Senturk, M; Ketenci, I; Erkorkmaz, U; Unlu, Y. Efficacy of bupivacaine for post-tonsillectomy pain: a study with the intra-individual design. Int J Pediatr Otorhinolaryngol; 2004; 68, pp. 1391-1395. [DOI: https://dx.doi.org/10.1016/j.ijporl.2004.05.006] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15488969]
27. Arikan, OK; Ozcan, S; Kazkayasi, M; Akpinar-Koc, C. Preincisional infiltration of tonsils with ropivacaine in posttonsillectomy pain relief: double-blind, randomized, placebocontrolled intraindividual study. J Otolaryngol; 2006; 35, pp. 167-172. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16929992]
28. Unal, Y; Pampal, K; Korkmaz, S; Arslan, M; Zengin, A; Kurtipek, O. Comparison of bupivacaine and ropivacaine on post-operative pain after tonsillectomy in paediatric patients. Int J Pediatr Otorhinolaryngol; 2007; 71, pp. 83-87. [DOI: https://dx.doi.org/10.1016/j.ijporl.2006.09.005] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17087998]
29. Haksever, M; Özmen, S; Akduman, D; Solmaz, F. Topical bupivacaine compared to bupivacaine infiltration for post-tonsillectomy pain relief in children: a prospective randomized controlled clinical study. Eur Arch Otorhinolaryngol; 2014; 271, pp. 2555-2559. [DOI: https://dx.doi.org/10.1007/s00405-014-3022-6] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24691852]
30. Ergil, J; Akkaya, T; Gozaydin, O; Gunsoy, B; Alicura, S; Aladag, E et al. Vasoconstrictive and analgesic efficacy of locally infiltrated levobupivacaine in tonsillectomy patients. Int J Pediatr Otorhinolaryngol; 2012; 76, pp. 1429-1433. [DOI: https://dx.doi.org/10.1016/j.ijporl.2012.06.016] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22776810]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background
This study aims to compare the topical administration of bupivacaine hydrochloride and lidocaine hydrochloride with epinephrine in alleviating post-tonsillectomy pain. Post-tonsillectomy pain has remained a challenge to both patient and doctors, and local anaesthetic agents applied to the tonsillar fossae post-operatively look promising.
Methods
One hundred and twenty ASA I or II children aged 2–15 years of consenting parents undergoing adenoidectomy and/or tonsillectomy were enrolled in the study. This was a randomized double-blind study in which the children were allocated into either of two groups to receive 5 ml of 0.125% bupivacaine or equal volume of lidocaine plus 1:200,000 adrenaline-soaked swab applied directly on the tonsillar floor within the fossae and/or nasopharynx after haemostasis was secured for 5 min before discontinuation of anaesthesia.
Results
Patients in the bupivacaine group had better extubating condition (p = 0.0001). There was no difference in the time to eye opening in both groups (p-value 0.316). Patients in the lidocaine group had a time to first analgesic request between 1 and 6 h, whereas in the bupivacaine group, about 25 patients (44% of the group) had a time to first analgesic request that exceeded 6 h (6–10 h). The only complication recorded in both groups following oral feeds was vomiting, and there was no difference in both groups (p = 0.968). Overall parental satisfaction was better with bupivacaine group (p = 0.00001).
Conclusion
Topical application of bupivacaine was associated with better extubation conditions and parental satisfaction when compared to topical lidocaine plus adrenaline while both demonstrated similar time to eye opening, analgesic request, haemodynamic parameters and incidence of complications.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Ilorin/University of Ilorin Teaching Hospital, Reader/Consultant Anaesthetist Department of Anaesthesia, Ilorin, Nigeria (GRID:grid.412975.c) (ISNI:0000 0000 8878 5287)
2 University of Ilorin Teaching Hospital, Senor Registrar Anaesthetist, Department of Anaesthesia, Ilorin, Nigeria (GRID:grid.412975.c) (ISNI:0000 0000 8878 5287)
3 Professor /Consultant Anaesthetist, Department of Anaesthesia, University of Ilorin/University of Ilorin Teaching Hospital, Ilorin Kwara State, Nigeria (GRID:grid.412975.c) (ISNI:0000 0000 8878 5287)
4 University of Ilorin Teaching Hospital, Consultant ENT Surgeon, Department of Otorhinolaryngology, Head and Neck Surgery, Ilorin, Nigeria (GRID:grid.412975.c) (ISNI:0000 0000 8878 5287)
5 University of Ilorin/University of Ilorin Teaching Hospital, Professor/ Consultant ENT Surgeon, Department of Otorhinolaryngology, Head and Neck Surgery, Ilorin, Nigeria (GRID:grid.412975.c) (ISNI:0000 0000 8878 5287)
6 Federal medical centre Abeokuta, Ogun State, 5Consultant ENT Surgeon, Department of Otorhinolaryngology, Abeokuta, Nigeria (GRID:grid.414821.a)